oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options
Department of Dermatology, Ghent University Hospital, Ghent, Belgium; Wound Care Centre, Ghent University Hospital, Ghent, Belgium.
Wound Care Centre, Ghent University Hospital, Ghent, Belgium.
Skin Integrity Research Group (SKINT), Department of Public Health, University Centre for Nursing and Midwifery, Ghent University, Ghent, Belgium.
Skin Integrity Research Group (SKINT), Department of Public Health, University Centre for Nursing and Midwifery, Ghent University, Ghent, Belgium.ORCID iD: 0000-0003-3080-8716
2018 (English)In: Drugs & Aging, ISSN 1170-229X, E-ISSN 1179-1969, Vol. 35, no 1, p. 1-10Article in journal (Refereed) Published
Abstract [en]

Incontinence-associated dermatitis (IAD) is a common type of irritant contact dermatitis, seen in patients with urinary or faecal incontinence. Mechanical factors such as traumata and friction may aggravate the lesions. The fragile skin in elderly patients is more prone to developing IAD. The clinical picture of IAD consists of persistent redness on the one hand and skin loss on the other. Both categories may be associated with clinical signs of major colonisation or infection. It is important to distinguish IAD from pressure ulcers and other dermatoses in the genital region. Due to the lack of well-established clinical trials, recommendations about prevention and treatment are based on expert opinion and best practice. Gentle cleansing, use of hydrating topical agents and application of barrier products are the main elements in the prevention and treatment of IAD. It is important to translate these recommendations and general guidelines into ready-to-use protocols that can be implemented for each specific clinical manifestation of IAD.

Place, publisher, year, edition, pages
Wolters Kluwer, 2018. Vol. 35, no 1, p. 1-10
National Category
Nursing
Identifiers
URN: urn:nbn:se:oru:diva-73171DOI: 10.1007/s40266-017-0507-1ISI: 000424295100001PubMedID: 29243033Scopus ID: 2-s2.0-85038087100OAI: oai:DiVA.org:oru-73171DiVA, id: diva2:1296484
Available from: 2019-03-15 Created: 2019-03-15 Last updated: 2019-06-18Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Beeckman, Dimitri

Search in DiVA

By author/editor
Beeckman, Dimitri
In the same journal
Drugs & Aging
Nursing

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 47 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf